Investors.humacyte.com

Investor Relations Humacyte, Inc.

WEBHumacyte, Inc., is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve …

Actived: 1 days ago

URL: https://investors.humacyte.com/

Results From Mayo Clinic Clinical Study of Humacyte’s Human …

WEB-Researchers concluded that in the clinical study the HAV was a safe, resilient, and effective conduit for arterial bypass and limb salvage-DURHAM, N.C., …

Category:  Health Go Health

Humacyte First Quarter 2024 Financial Results and Business Update

WEBFirst Quarter 2024 Financial Highlights. The Company reported cash and cash equivalents of $115.5 million as of March 31, 2024. Total net cash provided was …

Category:  Health Go Health

Humacyte Third Quarter 2023 Financial Results and Business Update

WEBResearch and development expenses were $18.6 million for the third quarter of 2023, compared to $17.3 million for the third quarter of 2022, and were $56.4 million for the …

Category:  Health Go Health

Press Releases Humacyte, Inc.

WEBDURHAM, N.C. , March 18, 2024 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally …

Category:  Health Go Health

Humacyte, Inc. to Present at the TD Cowen 44th Annual Health …

WEBHumacyte, Inc. to Present at the TD Cowen 44th Annual Health Care Conference. DURHAM, N.C., March 01, 2024 (GLOBE NEWSWIRE) -- Humacyte, Inc. …

Category:  Health Go Health

Humacyte First Quarter 2022 Financial Results and Business Update

WEBRevenue was $233 thousand for the first quarter of 2022, compared to $155 thousand for the first quarter of 2021. Revenue in both periods related to grants …

Category:  Health Go Health

Humacyte Announces Successful Closing of Business Combination …

WEBHumacyte raises $245M gross proceeds Combined company is expected to begin trading on the Nasdaq Global Select Market® under “HUMA” and “HUMAW” on …

Category:  Health Go Health

Humacyte Announces Presentation on Investigational Human …

WEBDr. Todd E. Rasmussen provides HAV™ clinical update and surgical skills workshop at ICMM. DURHAM, N.C., Sept. 09, 2022 (GLOBE NEWSWIRE) -- Humacyte, …

Category:  Health Go Health

Events & Presentations Humacyte, Inc.

WEBThe Investor Relations website contains information about Humacyte, Inc.'s business for stockholders, potential investors, and financial analysts.

Category:  Health Go Health

Humacyte, a Transformative Biotechnology Platform Company …

WEBHumacyte aims to transform medicine with off-the-shelf, universally implantable, bioengineered human tissue available at commercial scale. Transaction values …

Category:  Medicine Go Health

Humacyte Announces Clinical Case Series Demonstrating Potential …

WEB– Outcomes of first eight compassionate use cases presented at 46th Annual Winter Meeting of the Vascular and Endovascular Surgery Society – – HAV observed to …

Category:  Health Go Health

Alpha Healthcare Acquisition Corp. Announces Shareholder …

WEBNEW YORK and DURHAM, N.C., Aug. 24, 2021 (GLOBE NEWSWIRE) -- Alpha Healthcare Acquisition Corp. (Nasdaq: AHAC) (“AHAC”), a special purpose acquisition company, …

Category:  Health Go Health

Humacyte Presents Clinical Performance of Human Acellular …

WEB-Clinical outcomes presented at Military Health System Research Symposium (MHSRS)- -Results will be included in Biologics License Application (BLA) …

Category:  Health Go Health

Humacyte Awarded ‘Large Project Prototype of the Year’ from The …

WEBHonor Recognizes Humacyte’s Progress in Accelerating the Manufacturing Platform and Process for Producing Vascular Conduits for Hemodialysis and Vascular …

Category:  Health Go Health

Humacyte Provides Update on Patients Treated at Front-Line …

WEB-- Successful first two HAV implantations in wounded Ukrainian citizens -- HAVs were provided under Humacyte’s initiative to assist Ukraine humanitarian medical effort -- …

Category:  Medical Go Health

Humacyte Appoints Founder Laura Niklason MD, PhD as President …

WEBJeffrey Lawson MD, PhD Appointed Chief Surgical Officer and Vice Chairman, to Enhance Product Positioning and Clinical Adoption. DURHAM, N.C. -- …

Category:  Health Go Health

Humacyte Announces Two Presentations at the …

WEB– Presentations included results from Phase 2/3 clinical trial and outcomes of real-world use of the HAV under a humanitarian aid program to treat wartime injuries in Ukraine – – …

Category:  Health Go Health

Humacyte Announces JAMA Surgery Publication Highlighting …

WEB-- HAV implanted in nearly 500 patients with more than 1,000 patient-years of follow up to date, for treatment of peripheral arterial disease, arteriovenous access for …

Category:  Health Go Health

Humacyte CEO Dr. Laura Niklason to Present at J.P. Morgan …

WEBDURHAM, N.C., Jan. 11, 2021 /PRNewswire/ -- Humacyte, Inc., a leading innovator in regenerative medicine and biotechnology, announced that Founder and CEO Laura …

Category:  Medicine Go Health

Humacyte to Participate in Fireside Chat at BTIG MedTech, Digital

WEBDURHAM, N.C., Feb. 09, 2022 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable …

Category:  Health Go Health

Alpha Healthcare and Humacyte Announce Nominees for Election …

WEBNominees bring depth and diversity of scientific, commercial and financial experience to Board; NEW YORK and DURHAM, N.C., Aug. 13, 2021 (GLOBE NEWSWIRE) -- Alpha …

Category:  Health Go Health